Skip to content

Assessment of Intellectual Abilities for Subjects With Velopharyngeal Incompetence and Their Impact on Speech Intelligibility

Assessment of Intellectual Abilities for Subjects With Velopharyngeal Incompetence and Their Impact on Speech Intelligibility

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03898713
Enrollment
100
Registered
2019-04-02
Start date
2019-07-01
Completion date
2020-07-01
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Velopharyngeal Incompetence Due to Cleft Palate

Keywords

IQ, Speech, VPI

Brief summary

To Assess effect of intelligence on speech production on subjects with velopharyngeal incompetence Search if there is any relation between congenital Velopharyngeal incompetence and decrease IQ of patients

Detailed description

Speech production is a complex process by which thoughts are generated into spoken utterances. Production involves the selection of appropriate words and the appropriate form of those words from the lexicon and morphology, and the organization of those words through the syntax. Then, the phonetic properties of the words are retrieved and the sentence is uttered through the articulations associated with those phonetic properties. The term intelligibility refers to 'speech clarity' or the proportion of a speaker's output that a listener can readily understand. Velopharyngeal Incompetence (VPI) refers to any situation in which an individual is unable to completely close the nasal airway during speech. The velopharyngeal mechanism is comprised of a complex group of structures that act in unison to control airflow through the nose and mouth by elevation of the soft palate and constriction of both the lateral and posterior pharyngeal walls. Any disruption in this mechanism may result in abnormal, poorly intelligible speech. VPI can manifest as hypernasality, nasal emission, decreased vocal intensity, and/or facial grimacing. Intellectual ability refers to the skills required to think critically, see connections between disciplines and problem solve in new or changing situations. Memory, creative problem solving and vocabulary also contribute to the level of an individual's intellectual ability. Orofacial clefts (OFCs) are frequently occurring human birth defects that have a complex, multifactorial etiology. Though structural orofacial defects are often surgically corrected during infancy and early childhood, OFC patient cohorts are at high risk for neurobehavioral problems including learning disability, impaired language function, psychosocial adjustment issues, and persistently reduced academic achievement.

Interventions

DIAGNOSTIC_TESTIntelligence quotient

intelligence quotient (IQ) is a total score derived from several standardized tests designed to assess human intelligence

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 25 Years

Inclusion criteria

* children with cleft lip and palate primary or secondary repaired * Velopharyngeal incompetence due to any cause especially short palate and deep pharynx * children above 3 years

Exclusion criteria

* Hearing impairment * Neurological disease * ADHD

Design outcomes

Primary

MeasureTime frameDescription
Auditory perceptual assessmentBaselineAuditory-perceptual evaluation is the most commonly used clinical voice assessment method, and is often considered a gold standard for documentation of voice disorders.
IQ testBaselineAssess IQ level of patients by standford binet version 4. An intelligence quotient (IQ) is a total score derived from several standardized tests designed to assess human intelligence. This is to search if there is any relation between IQ level and VPI and effect on speech intelligability

Contacts

Primary ContactZeinab Soliman, Resident Dr.
smile0smile@hotmail.com01018119004
Backup ContactEman Abdel Haleem, Prof. Dr.
emadkamelabdelhaleem@aun.edu.eg01064228598

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026